109 related articles for article (PubMed ID: 17011336)
21. Prescribed stimulant use by Western Australians with Attention Deficit Hyperactivity Disorder (ADHD): does amount dispensed exceed the expected authorised use?
Calver J; Sanfilippo F; Preen D; Bulsara M
Aust N Z J Public Health; 2007 Dec; 31(6):533-9. PubMed ID: 18081573
[TBL] [Abstract][Full Text] [Related]
22. Donepezil use in children and adolescents with tics and attention-deficit/hyperactivity disorder: an 18-week, single-center, dose-escalating, prospective, open-label study.
Cubo E; Fernández Jaén A; Moreno C; Anaya B; González M; Kompoliti K
Clin Ther; 2008 Jan; 30(1):182-9. PubMed ID: 18343255
[TBL] [Abstract][Full Text] [Related]
23. Do maternal attention-deficit/hyperactivity disorder symptoms exacerbate or ameliorate the negative effect of child attention-deficit/hyperactivity disorder symptoms on parenting?
Psychogiou L; Daley DM; Thompson MJ; Sonuga-Barke EJ
Dev Psychopathol; 2008; 20(1):121-37. PubMed ID: 18211731
[TBL] [Abstract][Full Text] [Related]
24. [Sociodemographic and clinical factors associated with compliance to methylphenidate treatment in children with attention deficit hyperactivity disorder].
Kiliç BG; Bilgiç A; Gürkan K; Aysev A
Turk Psikiyatri Derg; 2007; 18(3):207-13. PubMed ID: 17853975
[TBL] [Abstract][Full Text] [Related]
25. Increased cerebral perfusion in adult attention deficit hyperactivity disorder is normalised by stimulant treatment: a non-invasive MRI pilot study.
O'Gorman RL; Mehta MA; Asherson P; Zelaya FO; Brookes KJ; Toone BK; Alsop DC; Williams SC
Neuroimage; 2008 Aug; 42(1):36-41. PubMed ID: 18511306
[TBL] [Abstract][Full Text] [Related]
26. Poor utility of the age of onset criterion for DSM-IV attention deficit/hyperactivity disorder: recommendations for DSM-V and ICD-11.
Todd RD; Huang H; Henderson CA
J Child Psychol Psychiatry; 2008 Sep; 49(9):942-9. PubMed ID: 18564071
[TBL] [Abstract][Full Text] [Related]
27. A novel multidomain computerized cognitive assessment for attention-deficit hyperactivity disorder: evidence for widespread and circumscribed cognitive deficits.
Leitner Y; Doniger GM; Barak R; Simon ES; Hausdorff JM
J Child Neurol; 2007 Mar; 22(3):264-76. PubMed ID: 17621495
[TBL] [Abstract][Full Text] [Related]
28. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.
Biederman J; Melmed RD; Patel A; McBurnett K; Konow J; Lyne A; Scherer N;
Pediatrics; 2008 Jan; 121(1):e73-84. PubMed ID: 18166547
[TBL] [Abstract][Full Text] [Related]
29. [Diagnosis and therapeutic guideline for attention deficit hyperkinetic syndrome (ADHD)].
Saito M
Seishin Shinkeigaku Zasshi; 2005; 107(2):167-79. PubMed ID: 15909379
[No Abstract] [Full Text] [Related]
30. Overweight in children and adolescents in relation to attention-deficit/hyperactivity disorder: results from a national sample.
Waring ME; Lapane KL
Pediatrics; 2008 Jul; 122(1):e1-6. PubMed ID: 18595954
[TBL] [Abstract][Full Text] [Related]
31. Frontiers between attention deficit hyperactivity disorder and bipolar disorder.
Galanter CA; Leibenluft E
Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):325-46, viii-ix. PubMed ID: 18295149
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of attention-deficit/hyperactivity disorder symptoms in male children with high-functioning pervasive developmental disorders.
Matsushima N; Miyawaki D; Tsuji H; Takahashi K; Horino A; Kawaguchi T; Suzuki F; Kiriike N
Osaka City Med J; 2008 Jun; 54(1):1-10. PubMed ID: 18819260
[TBL] [Abstract][Full Text] [Related]
33. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
Huang YS; Guilleminault C; Li HY; Yang CM; Wu YY; Chen NH
Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069
[TBL] [Abstract][Full Text] [Related]
34. Twin study on transplacental-acquired antibodies and attention deficit/hyperactivity disorder--a pilot study.
Bilenberg N; Hougaard D; Norgaard-Pedersen B; Nordenbæk CM; Olsen J
J Neuroimmunol; 2011 Jul; 236(1-2):72-5. PubMed ID: 21601295
[TBL] [Abstract][Full Text] [Related]
35. Pervasive developmental disorder with attention deficit hyperactivity disorder-like symptoms and mismatch negativity.
Sawada M; Negoro H; Iida J; Kishimoto T
Psychiatry Clin Neurosci; 2008 Aug; 62(4):479-81. PubMed ID: 18778448
[TBL] [Abstract][Full Text] [Related]
36. Attention-deficit/hyperactivity disorder: advances in diagnostic and therapeutic approaches.
DelBello MP
J Clin Psychiatry; 2008 Jan; 69(1):130. PubMed ID: 18312047
[No Abstract] [Full Text] [Related]
37. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
Visser SN; Lesesne CA; Perou R
Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
[TBL] [Abstract][Full Text] [Related]
38. Nature of anxiety comorbid with attention deficit hyperactivity disorder in children from a pediatric primary care setting.
Bowen R; Chavira DA; Bailey K; Stein MT; Stein MB
Psychiatry Res; 2008 Jan; 157(1-3):201-9. PubMed ID: 18023880
[TBL] [Abstract][Full Text] [Related]
39. Sleep characteristics of children and adolescents with attention deficit-hyperactivity disorder.
Gruber R
Child Adolesc Psychiatr Clin N Am; 2009 Oct; 18(4):863-76. PubMed ID: 19836693
[TBL] [Abstract][Full Text] [Related]
40. [Neuropsychological assessment of the effectiveness of OROS-methylphenidate in attention deficit hyperactivity disorder].
Rubio-Morell B; Martín-González R; Herreros-Rodríguez O; González-Pérez P; Hernández-Exposito S; Quintero-Fuentes I; Gracia-Marco R
Rev Neurol; 2008 May 16-31; 46(10):602-8. PubMed ID: 18465700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
